KANTOFF, PHILIP W.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

51

Expression of lncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancer

Sun, Tong, Du, Shin-Yi, Armenia, Joshua, Qu, Fangfang, Fan, Jingyu, Wang, Xiaodong, Fei, Teng, Komura, Kazumasa, Liu, Shirley X., Lee, Gwo-Shu Mary, Kantoff, Philip W

Journal:

Year:

2018

Language:

english

File:

PDF, 2.11 MB

english, 2018

52

MP21-02 PROSTATE CANCER INCIDENCE AND MORTALITY AMONG MEN USING STATINS AND NON-STATIN LIPID-LOWERING MEDICATIONS

Van Rompay, Maria I., Solomon, Keith R., Ranganathan, Gayatri, Nickel, J. Curtis, Kantoff, Philip W., McKinlay, John B.

Journal:

The Journal of Urology

Year:

2018

Language:

english

File:

PDF, 225 KB

english, 2018

53

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer

Mazzu, Ying Z., Armenia, Joshua, Nandakumar, Subhiksha, Chakraborty, Goutam, Yoshikawa, Yuki, Jehane, Lina E., Lee, GwoâShu Mary, Atiq, Mohammad, Khan, Nabeela, Schultz, Nikolaus, Kantoff, Philip W.

Journal:

Molecular Oncology

Year:

2020

File:

PDF, 25.30 MB

2020

54

p53 Protein Expression Status and Recurrence in Men Treated with Radiation and Androgen Suppression Therapy for Higher-Risk Prostate Cancer: A Prospective Phase II Cancer and Leukemia Group B Study (CALGB 9682)

Anthony V. D'Amico, Susan Halabi, Robin Vollmer, Marian Loffredo, Elizabeth McMahon, Ben Sanford, Laura Archer, Nicholas J. Vogelzang, Eric J. Small, Philip W. Kantoff

Journal:

Year:

2008

Language:

english

File:

PDF, 208 KB

english, 2008

55

Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma

Ronald A. Ghossein, Juan Rosai, Howard I. Scher, Michael Seiden, Zuo-Feng Zhang, Ming Sun, Gloria Chang, Karen Berlane, Krishna Krithivas, Philip W. Kantoff

Journal:

Year:

1997

Language:

english

File:

PDF, 629 KB

english, 1997

56

COMPARING PROSTATE SPECIFIC ANTIGEN OUTCOMES AFTER DIFFERENT TYPES OF RADIOTHERAPY MANAGEMENT OF CLINICALLY LOCALIZED PROSTATE CANCER HIGHLIGHTS THE IMPORTANCE OF CONTROLLING FOR ESTABLISHED PROGNOSTIC FACTORS

D’AMICO, ANTHONY V., SCHULTZ, DELRAY, SCHNEIDER, LINDSEY, HURWITZ, MARK, KANTOFF, PHILIP W., RICHIE, JEROME P.

Journal:

The Journal of Urology

Year:

2000

Language:

english

File:

PDF, 61 KB

english, 2000

57

Production of Glycosylated Physiologically ``Normal'' Human α1-antitrypsin by Mouse Fibroblasts Modified by Insertion of a Human α1-antitrypsin cDNA Using a Retroviral Vector

Robert I. Garver, Anna Chytil, Stefan Karlsson, Gerald A. Fells, Mark L. Brantly, Michael Courtney, Philip W. Kantoff, Arthur W. Nienhuis, W. French Anderson and Ronald G. Crystal

Journal:

Proceedings of the National Academy of Sciences

Year:

1987

Language:

english

File:

PDF, 1.02 MB

english, 1987

58

New Developments in the Management of Prostate Cancer

Kantoff, Philip W., Mohler, James L.

Journal:

Journal of the National Comprehensive Cancer Network

Year:

2013

Language:

english

File:

PDF, 270 KB

english, 2013

59

Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials

Atkins, Katelyn M., Chen, Ming-Hui, Wu, Jing, Renshaw, Andrew A., Loffredo, Marian, Kantoff, Philip W., Small, Eric J., D'Amico, Anthony V.

Journal:

Year:

2017

Language:

english

File:

PDF, 412 KB

english, 2017

60

Event-Free Survival, a Prostate-Specific AntigenâBased Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation

Xie, Wanling, Regan, Meredith M., Buyse, Marc, Halabi, Susan, Kantoff, Philip W., Sartor, Oliver, Soule, Howard, Berry, Donald, Clarke, Noel, Collette, Laurence, DâAmico, Anthony, Lourenco, Richard

Journal:

Journal of Clinical Oncology

Year:

2020

File:

PDF, 783 KB

2020

61

A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma

William K. Oh, Judith Manola, Jerome P. Richie, Kevin R. Loughlin, Philip W. Kantoff

Journal:

Year:

1999

Language:

english

File:

PDF, 78 KB

english, 1999

62

Meningeal carcinomatosis from transitional cell carcinoma of the bladder

Charis Eng, David Cunningham, Bradley J. Quade, Lee Schwamm, Philip W. Kantoff, Arthur T. Skarin

Journal:

Year:

1993

Language:

english

File:

PDF, 528 KB

english, 1993

63

Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy

Andrew Z. Wang, Vaishali Bagalkot, Christophoros C. Vasilliou, Frank Gu, Frank Alexis, Liangfang Zhang, Mariam Shaikh, Kai Yuet, Michael J. Cima, Robert Langer, Philip W. Kantoff, Neil H. Bander, Sang

Journal:

Year:

2008

Language:

english

File:

PDF, 500 KB

english, 2008

64

Differentiating agents and the treatment of prostate cancer: vitamin D3 and peroxisome proliferator-activated receptor gamma ligands

Stacey B Leibowitz, Philip W Kantoff

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 117 KB

english, 2003

65

Department of Defense Prostate Cancer Clinical Trials Consortium: A New Instrument for Prostate Cancer Clinical Research

Michael J. Morris, Ethan M. Basch, George Wilding, Maha Hussain, Michael A. Carducci, Celestia Higano, Philip Kantoff, William K. Oh, Eric J. Small, Daniel George, Paul Mathew, Tomasz M. Beer, Susan F

Journal:

Clinical Genitourinary Cancer

Year:

2009

Language:

english

File:

PDF, 155 KB

english, 2009

66

Self-Inactivating Retroviral Vectors Designed for Transfer of Whole Genes into Mammalian Cells

Sheau-Fung Yu, Thomas Von Rüden, Philip W. Kantoff, Christa Garber, Miri Seiberg, Ulrich Rüther, W. French Anderson, Erwin F. Wagner and Eli Gilboa

Journal:

Proceedings of the National Academy of Sciences

Year:

1986

Language:

english

File:

PDF, 1.02 MB

english, 1986

67

Does androgen deprivation therapy in men with prostate cancer increase cardiovascular morbidity?

Corsello, Steven M, Kantoff, Philip W

Journal:

Nature Clinical Practice Urology

Year:

2008

Language:

english

File:

PDF, 173 KB

english, 2008

68

Prostate Cancer, Version 1.2014

Mohler, James L., Kantoff, Philip W., Armstrong, Andrew J., Bahnson, Robert R., Cohen, Michael, D’Amico, Anthony Victor, Eastham, James A., Enke, Charles A., Farrington, Thomas A., Higano, Celestia S.

Journal:

Journal of the National Comprehensive Cancer Network

Year:

2013

Language:

english

File:

PDF, 253 KB

english, 2013

69

GENETIC DETERMINANTS OF PROSTATE CANCER RISK

Mark M. Pomerantz, Matthew L. Freedman, Philip W. Kantoff

Journal:

BJU International

Year:

2007

Language:

english

File:

PDF, 102 KB

english, 2007

70

Peroxisome Proliferator-Activated Receptor Gamma (PPARγ as a Novel Target for Prostate Cancer

Matthew R. Smith, Philip W. Kantoff

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 146 KB

english, 2002

71

ATAAA repeat upstream of glutathione S-transferase P1 and prostate cancer risk

Elizabeth A Platz, Krishna Krithivas, Philip W Kantoff, Meir J Stampfer, Edward Giovannucci

Journal:

Year:

2002

Language:

english

File:

PDF, 109 KB

english, 2002

72

Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer

Nadeem A. Sheikh, Daniel Petrylak, Philip W. Kantoff, Corazon dela Rosa, Frances P. Stewart, Ling-Yu Kuan, James B. Whitmore, James B. Trager, Christian H. Poehlein, Mark W. Frohlich, David L. Urdal

Journal:

Cancer Immunology, Immunotherapy

Year:

2013

Language:

english

File:

PDF, 561 KB

english, 2013

73

Long-term Follow-up of a Phase II Trial of Chemotherapy Plus Hormone Therapy for Biochemical Relapse After Definitive Local Therapy for Prostate Cancer

Nakabayashi, Mari, Xie, Wanling, Buckle, Geoffrey, Bubley, Glenn, Ernstoff, Marc S., Walsh, William, Morganstern, Daniel E., Kantoff, Philip W., Taplin, Mary-Ellen

Journal:

Year:

2013

Language:

english

File:

PDF, 164 KB

english, 2013

74

Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer

Hayes, Julia H., Ollendorf, Daniel A., Pearson, Steven D., Barry, Michael J., Kantoff, Philip W., Stewart, Susan T., Bhatnagar, Vibha, Sweeney, Christopher J., Stahl, James E., McMahon, Pamela M.

Journal:

JAMA The Journal of the American Medical Association

Year:

2010

Language:

english

File:

PDF, 280 KB

english, 2010

75

MP50-20 IMPACT OF ABIRATERONE ACETATE IN PROSTATE SPECIFIC ANTIGEN TRIAL UPDATE: EFFECT OF ABIRATERONE ACETATE AND LOW DOSE PREDNISONE ON PROSTATE-SPECIFIC ANTIGEN AND RADIOGRAPHIC DISEASE PROGRESSION IN PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Ryan, Charles, Crawford, E. David, Shore, Neal D, Underwood, Willie, Londhe, Anil, Black, Shawn, McGowan, Tracy, Kantoff, Philip W.

Journal:

The Journal of Urology

Year:

2016

Language:

english

File:

PDF, 309 KB

english, 2016

76

14-Day Continuous Infusion of Mitoxantrone in Hormone-Refractory Metastatic Adenocarcinoma of the Prostate

Kantoff, Philip W., Block, Caroline, Letvak, Laurie, George, Marline

Journal:

American Journal of Clinical Oncology

Year:

1993

File:

PDF, 207 KB

1993

77

Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer

Hearn, Jason W. D., Xie, Wanling, Nakabayashi, Mari, Almassi, Nima, Reichard, Chad A., Pomerantz, Mark, Kantoff, Philip W., Sharifi, Nima

Journal:

Year:

2017

Language:

english

File:

PDF, 265 KB

english, 2017

78

Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survival

Xie, Wanling, Stopsack, Konrad H., Drouin, Sarah J., Fu, Henry, Pomerantz, Mark M., Mucci, Lorelei A., Lee, Gwo-Shu M., Kantoff, Philip W.

Journal:

Year:

2018

Language:

english

File:

PDF, 708 KB

english, 2018

79

Aneuploidy drives lethal progression in prostate cancer

Stopsack, Konrad H., Whittaker, Charles A., Gerke, Travis A., Loda, Massimo, Kantoff, Philip W., Mucci, Lorelei A., Amon, Angelika

Journal:

Proceedings of the National Academy of Sciences

Year:

2019

Language:

english

File:

PDF, 1.25 MB

english, 2019

80

Patterns of self-reported care in a cohort of prostate cancer survivors: Implications for risk-stratified care

Nekhlyudov, Larissa, Blackmon, Jaime E., Kantoff, Philip, Recklitis, Christopher J.

Journal:

Journal of Geriatric Oncology

Year:

2020

Language:

english

File:

PDF, 228 KB

english, 2020

81

Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer

Stopsack, Konrad H, Gerke, Travis, Zareba, Piotr, Pettersson, Andreas, Chowdhury, Dipanjan, Ebot, Ericka M, Flavin, Richard, Finn, Stephen, Kantoff, Philip W, Stampfer, MeirÂ J, Loda, Massimo, Fiorent

Journal:

Year:

2020

File:

PDF, 358 KB

2020

82

Racial Differences in Genomic Profiling of Prostate Cancer

Mahal, Brandon A., Alshalalfa, Mohammed, Kensler, Kevin H., Chowdhury-Paulino, Ilkania, Kantoff, Philip, Mucci, Lorelei A., Schaeffer, Edward M., Spratt, Daniel, Yamoah, Kosj, Nguyen, Paul L., Rebbeck

Journal:

New England Journal of Medicine

Year:

2020

File:

PDF, 382 KB

2020

83

Regulation of S100P expression by androgen

Averboukh, Lidia, Liang, Peng, Kantoff, Philip W., Pardee, Arthur B.

Journal:

Year:

1996

Language:

english

File:

PDF, 531 KB

english, 1996

84

Secondary Hormonal Therapy in Men With Castration-Resistant Prostate Cancer

Mari Nakabayashi, Lillian Werner, William K. Oh, Meredith M. Regan, Philip W. Kantoff, Mary-Ellen Taplin

Journal:

Clinical Genitourinary Cancer

Year:

2011

Language:

english

File:

PDF, 443 KB

english, 2011

85

Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials

Anthony V D'Amico, Ming-Hui Chen, Mario de Castro, Marian Loffredo, David S Lamb, Allison Steigler, Philip W Kantoff, James W Denham

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 145 KB

english, 2012

86

Recent advances in immunotherapy for the treatment of prostate cancer

Sonpavde, Guru, Agarwal, Neeraj, Choueiri, Toni K, Kantoff, Philip W

Journal:

Expert Opinion on Biological Therapy

Year:

2011

Language:

english

File:

PDF, 462 KB

english, 2011

87

Lower Baseline Prostate-specific Antigen Is Associated With a Greater Overall Survival Benefit From Sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) Trial

Schellhammer, Paul F., Chodak, Gerald, Whitmore, James B., Sims, Robert, Frohlich, Mark W., Kantoff, Philip W.

Journal:

Year:

2013

Language:

english

File:

PDF, 288 KB

english, 2013

88

Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial

Kim, Miranda B., Chen, Ming-Hui, de Castro, Mário, Loffredo, Marian, Kantoff, Philip W., D'Amico, Anthony V.

Journal:

Year:

2013

Language:

english

File:

PDF, 314 KB

english, 2013

89

The Role of miRNAs in Prostate Cancer

Sun, Tong, McKay, Rana, Lee, Gwo-Shu Mary, Kantoff, Philip

Journal:

European Urology

Year:

2015

Language:

english

File:

PDF, 177 KB

english, 2015

90

Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma

Mullane, Stephanie A., Werner, Lillian, Guancial, Elizabeth A., Lis, Rosina T., Stack, Edward C., Loda, Massimo, Kantoff, Philip W., Choueiri, Toni K., Rosenberg, Jonathan, Bellmunt, Joaquim

Journal:

Clinical Genitourinary Cancer

Year:

2015

Language:

english

File:

PDF, 1.06 MB

english, 2015

91

A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration-resistant prostate cancer

Choudhury, Atish D., Gray, Kathryn P., Supko, Jeffrey G., Harshman, Lauren C., Taplin, Mary-Ellen, Pace, Amanda F., Farina, Matthew, Zukotynski, Katherine A., Bernard, Brandon, Kantoff, Philip W., Pom

Journal:

Year:

2018

Language:

english

File:

PDF, 855 KB

english, 2018

92

Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics

Nguyen, Bastien, Mota, Jose Mauricio, Nandakumar, Subhiksha, Stopsack, Konrad H., Weg, Emily, Rathkopf, Dana, Morris, Michael J., Scher, Howard I., Kantoff, Philip W., Gopalan, Anuradha, Zamarin, Dmit

Journal:

European Urology

Year:

2020

File:

PDF, 1.10 MB

2020

93

Hormonal perturbations in patients with testicular cancer treated with cisplatin

Gerald A. Leblanc, Philip W. Kantoff, Sze-Fong Ng, Emil Frei III, David J. Waxman

Journal:

Year:

1992

Language:

english

File:

PDF, 480 KB

english, 1992

94

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

Anthony V. D'Amico, Tara Saegaert, Ming-Hui Chen, Andrew A. Renshaw, Daniel George, William Oh, Philip W. Kantoff

Journal:

Year:

2002

Language:

english

File:

PDF, 80 KB

english, 2002

95

Interval to Testosterone Recovery After Hormonal Therapy for Prostate Cancer and Risk of Death

Anthony V. D'Amico, Ming-Hui Chen, Andrew A. Renshaw, Marian Loffredo, Philip W. Kantoff

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2009

Language:

english

File:

PDF, 216 KB

english, 2009

96

Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer

Mari Nakabayashi, Meredith M. Regan, Deborah Lifsey, Philip W. Kantoff, Mary-Ellen Taplin, Oliver Sartor, William K. Oh

Journal:

BJU International

Year:

2005

Language:

english

File:

PDF, 76 KB

english, 2005

97

Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer

William K Oh, Daniel J George, Kristin Hackmann, Judith Manola, Philip W Kantoff

Journal:

Year:

2001

Language:

english

File:

PDF, 120 KB

english, 2001

98

Appointments.

Schellhammer, Paul F., Chodak, Gerald, Whitmore, James B., Sims, Robert, Frohlich, Mark W., Kantoff, Philip W.

Journal:

Year:

1896

Language:

english

File:

PDF, 216 KB

english, 1896

99

The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease

Keane, Florence K., Chen, Ming-Hui, Zhang, Danjie, Loffredo, Marian J., Kantoff, Philip W., Renshaw, Andrew A., D'Amico, Anthony V.

Journal:

Year:

2014

Language:

english

File:

PDF, 172 KB

english, 2014

100

A Phase II Trial of Interferon-Alpha and Toremifene in Advanced Renal Cell Cancer Patients

Oh, William K., Manola, Judith, George, Daniel J., Fierman, Abby, Fontaine-Rothe, Pamela, Morrissey, Stephanie, Prisby, Judith, Kaufman, Donald S., Shapiro, Charles L., Kantoff, Philip W., Smith, Matt

Journal:

Cancer Investigation

Year:

2002

Language:

english

File:

PDF, 134 KB

english, 2002

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски